Loading clinical trials...
Loading clinical trials...
A Randomized Study Evaluating 2 Dose Regimens of Dupilumab in Children ≥6 Months of Age Weighing ≥5 to <15 kg With Active Eosinophilic Esophagitis
Conditions
Interventions
dupilumab
Locations
8
United States
Phoenix Childrens Hospital
Phoenix, Arizona, United States
Children's Hospital Colorado
Aurora, Colorado, United States
GI Care for Kids LLC
Atlanta, Georgia, United States
Weill Cornell Medicine
New York, New York, United States
University of North Carolina, Bioinformatics Building
Chapel Hill, North Carolina, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Start Date
November 10, 2025
Primary Completion Date
June 19, 2028
Completion Date
October 9, 2028
Last Updated
April 8, 2026
NCT06693531
NCT06389994
NCT04394351
NCT03245840
NCT03581838
NCT02320981
Lead Sponsor
Regeneron Pharmaceuticals
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions